News

Press Release
December 9, 2024
Mayumana Healthcare B.V. Acquires Exclusive Distribution Rights for the Cerene® Cryotherapy Device in the Netherlands as a Treatment for Heavy Menstrual Bleeding
Read the Story
Press Release
October 3, 2022
Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device
Read the Story
Press Release
August 10, 2022
Channel Medsystems Announces Publication of Long-term Clinical Outcomes with Cerene® Cryotherapy for the Treatment of Heavy Menstrual Bleeding
Read the Story
Press Release
August 3, 2022
Heather Knight Joins Channel Medsystems Board of Directors
Read the Story
Press Release
April 1, 2022
Channel Medsystems Announces Appointment of Three Key Executives to Management Team and Expanded Launch of Cerene® Cryotherapy for Heavy Menstrual Bleeding
Read the Story
Press Release
January 26, 2022
Lisa Garrett Joins Channel Medsystems Board of Directors
Read the Story
Press Release
September 13, 2021
InnovaHealth Partners Invests in Channel Medsystems, Innovator in Women’s Health
Read the Story
Article
February 25, 2021
New tool helps women who suffer from heavy menstrual cycles
Read the Story
Press Release
July 24, 2020
Channel Medsystems® Receives FDA Approval of its Latest Cerene® Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding in the Office Setting
Read the Story
Press Release
December 18, 2019
Cerene® Cryotherapy Device Recognized in Popular Science’s 2019 “Best of What’s New” Awards
Read the Story
Press Release
April 2, 2019
Channel Medsystems® Receives U.S. FDA Approval of the Cerene® Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding
Read the Story
Press Release
August 23, 2017
Channel Medsystems® Secures $14.1mm Financing for Office-Based Treatment of Heavy Menstrual Bleeding
Read the Story
Press Release
June 26, 2017
Channel Medsystems® Earns CE Mark Approval for the Cerene® Cryotherapy Device
Read the Story
Press Release
March 20, 2017
Channel Medsystems® Completes Treatments in Largest Single-Arm Pivotal Study of Endometrial Ablation; Demonstrates Feasibility of Comfortable, Office-Based Procedure
Read the Story
Press Release
November 14, 2016
Channel Medsystems Secures IDE Approval and Treats First Women in the CLARITY Pivotal Study
Read the Story
Press Release
September 22, 2015
Channel Medsystems Secures $22 Million Series C Financing Led by Third Point Ventures Company Prepares to Initiate a Pivotal Study for its Novel, Office-Based Therapy for Women with Heavy Menstrual Bleeding
Read the Story
Press Release
November 22, 2013
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List
Read the Story
Press Release
November 22, 2013
Initial Studies of Channel Medsystems’ Cryothermic Therapy Demonstrate Preliminary Safety and Tolerability; Results Presented at the 42nd AAGL Global Congress
Read the Story
Press Release
November 12, 2013
Channel Medsystems Receives Health Canada Approval to Begin Clinical Evaluation of its Innovative Procedure for Heavy Menstrual Bleeding; Hires Mary Edwards as Senior Vice President, Clinical and Regulatory Affairs.
Read the Story
Press Release
September 15, 2013
Channel Medsystems® Names Ric Cote as President and CEO; Secures $9.7 Million Investment
Read the Story
More News